BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Transposagen Biopharmaceuticals, Inc. Announces the Availability of XTN™ TALENs Targeting Every Gene in the Human Genome


7/18/2012 11:04:12 AM

LEXINGTON, Ky., July 17, 2012 /PRNewswire/ -- Transposagen announced that XTN site-specific nucleases targeting each gene in the human genome are now available. Utilizing the FLASH high-throughput system (FLASH assembly of TALENs for high-throughput genome editing. Nature Biotechnology 30, 460-465 (2012)), Transposagen can produce a site-specific nuclease targeting nearly any gene in any genome with the fastest delivery time in the industry. The XTN site-specific nucleases, also referred to as TALENs, permit researchers to specifically cut any DNA sequence, allowing for the creation of gene knockouts, knock-ins and single base pair edits. Researchers can now search Transposagen's GENOME discovery database to choose any target. Transposagen will also perform custom cell line engineering and animal model creation using the XTN technology.

The XTN technology can be used in conjunction with Transposagen's other core technology, piggyBac, as the only system in the world that allows for Footprint-Free genetic engineering down to a single base pair (Bradley et al. Nature 2011). "Researcher's now have the ability to change a single base-pair or multiple base pairs in any genome without residual unwanted changes, such as the addition of a marker gene or recombinase site," said Eric Ostertag, President and CEO of Transposagen. The Footprint-Free genetic engineering system is expected to have applicability in the generation of cell lines and model organisms for functional genomics and the validation of genome-wide association studies (GWAS).

Transposagen is now offering XTN site-specific nucleases worldwide. Custom and off-the-shelf XTN reagents are available through Transposagen (http://www.transposagenbio.com/rats/xtn-tal-nucleases.html) and with the following distributors:

GENTAUR Molecular Products
APRO Life Science Institute Inc. - Japan
MJS Biolynx Inc. Canada
ITSI-Biosciences Inc.
DPC/LEBANON sarl Middle East
BioCat GmBh Germany, Austria & Switzerland

About Transposagen Biopharmaceuticals, Inc.
Transposagen Biopharmaceuticals, Inc., a Lexington, KY-based company, is a worldwide leader in technologies and services for genetic modification. Transposagen is dedicated to providing better disease models through genetic modification. Transposagen specializes in custom and off-the-shelf XTN site-specific nucleases, animal models, cell lines, stem cells and cutting-edge research tools and technologies to improve drug discovery and development research. These unique technologies and services for genetic modification give customers the ability to create nearly any genetic modification in any genome for both research and protein production purposes.

Media Contact:
Jack Crawford
info@transposagenbio.com
859-428-8561

SOURCE Transposagen Biopharmaceuticals, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES